• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症的机制与治疗策略进展

Advances in mechanism and treatment strategy of cancer.

作者信息

Zeng Ye

机构信息

Institute of Biomedical Engineering, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu 610041, China.

出版信息

Cell Mol Biol (Noisy-le-grand). 2018 May 15;64(6):1-3.

PMID:29808792
Abstract

Cancer is one of the most serious diseases with high incidence and high mortality rate threaten human health and quality of life. The researches on mechanisms of cancer development and metastasis, and effective and reasonable treatment strategies are of great significance. The traditional treatments for tumors such as surgery, radiotherapy, and chemotherapy have some benefits, but many drawbacks such as drug-resistance and side-effects. With the emergence of new therapeutic methods such as tumor-targeted drugs and immune drugs, the survival of cancer patients is improved, but reports on cardiac damage caused by therapeutic drugs are increasing.

摘要

癌症是发病率和死亡率都很高的最严重疾病之一,威胁着人类健康和生活质量。对癌症发生和转移机制以及有效合理治疗策略的研究具有重要意义。传统的肿瘤治疗方法,如手术、放疗和化疗有一定益处,但也存在许多缺点,如耐药性和副作用。随着肿瘤靶向药物和免疫药物等新治疗方法的出现,癌症患者的生存率有所提高,但关于治疗药物引起心脏损伤的报道也在增加。

相似文献

1
Advances in mechanism and treatment strategy of cancer.癌症的机制与治疗策略进展
Cell Mol Biol (Noisy-le-grand). 2018 May 15;64(6):1-3.
2
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.癌症的先进靶向疗法:药物纳米载体,化疗的未来。
Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23.
3
Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology.《2015年临床癌症进展:美国临床肿瘤学会抗癌进展年度报告》
J Clin Oncol. 2015 Mar 1;33(7):786-809. doi: 10.1200/JCO.2014.59.9746. Epub 2015 Jan 20.
4
[New therapeutic strategies in oncology].[肿瘤学中的新治疗策略]
Ann Pharm Fr. 2010 Jul;68(4):203-4. doi: 10.1016/j.pharma.2010.06.001.
5
[Advances in medical oncology].[医学肿瘤学进展]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Jun;28(3):305-10.
6
[Health care expenditures linked to the use of targeted therapies and diagnostic tests for cancer patients].[与癌症患者使用靶向治疗和诊断检测相关的医疗保健支出]
Med Sci (Paris). 2012 Mar;28 Spec No 1:19-23. doi: 10.1051/medsci/2012281s106. Epub 2012 Apr 9.
7
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.临床肿瘤进展 2011:美国临床肿瘤学会癌症进展年度报告。
J Clin Oncol. 2012 Jan 1;30(1):88-109. doi: 10.1200/JCO.2011.40.1919. Epub 2011 Dec 5.
8
Integrated patient and tumor genetic testing for individualized cancer therapy.个体化癌症治疗的患者和肿瘤基因联合检测。
Clin Pharmacol Ther. 2016 Feb;99(2):143-6. doi: 10.1002/cpt.294. Epub 2015 Nov 25.
9
Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity.多种膳食抗氧化剂可提高标准癌症疗法和实验性癌症疗法的疗效,并降低其毒性。
Integr Cancer Ther. 2004 Dec;3(4):310-22. doi: 10.1177/1534735404270936.
10
[Current problems in surgical oncology: 1. Theoretical models in oncology and their implications in surgical therapy].[外科肿瘤学的当前问题:1. 肿瘤学中的理论模型及其在外科治疗中的意义]
Chirurgia (Bucur). 2011 Jan-Feb;106(1):17-22.

引用本文的文献

1
A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers.FDA 批准的抗体药物偶联物在人类癌症中的临床疗效评价。
Mol Cancer. 2024 Mar 23;23(1):62. doi: 10.1186/s12943-024-01963-7.
2
Calreticulin Expression in Human Carcinomas: A Systematic Review and Meta-Analysis.钙网织蛋白在人类癌中的表达:系统评价和荟萃分析。
Asian Pac J Cancer Prev. 2023 Sep 1;24(9):2929-2940. doi: 10.31557/APJCP.2023.24.9.2929.
3
Anticancer Potentials of the Lignan Magnolin: A Systematic Review.《芝麻脂素的抗癌潜力:系统评价》
Molecules. 2023 Apr 23;28(9):3671. doi: 10.3390/molecules28093671.
4
Small molecule inhibitors for cancer metabolism: promising prospects to be explored.小分子抑制剂在癌症代谢中的应用:具有广阔前景的探索。
J Cancer Res Clin Oncol. 2023 Aug;149(10):8051-8076. doi: 10.1007/s00432-022-04501-4. Epub 2023 Mar 31.
5
Long non-coding RNA TMPO-AS1 serves as a tumor promoter in pancreatic carcinoma by regulating miR-383-5p/SOX11.长链非编码RNA TMPO-AS1通过调控miR-383-5p/SOX11在胰腺癌中发挥肿瘤促进作用。
Oncol Lett. 2021 Apr;21(4):255. doi: 10.3892/ol.2021.12517. Epub 2021 Feb 4.
6
Targeting Akt-associated microRNAs for cancer therapeutics.针对 Akt 相关 microRNAs 的癌症治疗策略。
Biochem Pharmacol. 2021 Jul;189:114384. doi: 10.1016/j.bcp.2020.114384. Epub 2020 Dec 24.
7
Transcriptome sequencing identifies genes associated with invasion of ovarian cancer.转录组测序鉴定出与卵巢癌侵袭相关的基因。
J Int Med Res. 2020 Sep;48(9):300060520950912. doi: 10.1177/0300060520950912.
8
HBV DNA integrates into upregulated ZBTB20 in patients with hepatocellular carcinoma.HBV DNA 整合到肝癌患者上调的 ZBTB20 中。
Mol Med Rep. 2020 Jul;22(1):380-386. doi: 10.3892/mmr.2020.11074. Epub 2020 Apr 16.
9
Radiation-resistance increased by overexpression of microRNA-21 and inhibition of its target PTEN in esophageal squamous cell carcinoma.miRNA-21 过表达和其靶基因 PTEN 抑制增加食管鳞癌细胞的辐射抗性。
J Int Med Res. 2020 Apr;48(4):300060519882543. doi: 10.1177/0300060519882543.
10
Research Progress on Tumor-Associated Macrophages and Inflammation in Cervical Cancer.肿瘤相关巨噬细胞与宫颈癌炎症的研究进展。
Biomed Res Int. 2020 Jan 29;2020:6842963. doi: 10.1155/2020/6842963. eCollection 2020.